Alopecia areata: What's new in the epidemiology, comorbidities, and pathogenesis?
- PMID: 37833164
- DOI: 10.1016/j.jdermsci.2023.09.008
Alopecia areata: What's new in the epidemiology, comorbidities, and pathogenesis?
Abstract
Background: Alopecia areata (AA) is a common, acquired, and nonscarring type of hair loss that affects people of every generation and is intractable in severe and relapsing cases. Patients with AA, especially those with greater scalp involvement, have poor health-related quality-of-life scores.
Purpose: Following our previous review article in the April 2017 issue of the Journal of Dermatological Science, we aim to provide a pair of review articles on recent progress in multidisciplinary approaches to AA.
Main findings: We found more than 1800 publications on AA from July 2016 to December 2022.
Conclusions: In this review, we focused on the latest information on the epidemiology, comorbidities, and pathogenesis of AA.
Keywords: Alopecia areata; Alopecia totalis; Alopecia universalis; Comorbidity; Epidemiology; Pathogenesis.
Copyright © 2023 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis.J Am Acad Dermatol. 2020 Mar;82(3):675-682. doi: 10.1016/j.jaad.2019.08.032. Epub 2019 Aug 19. J Am Acad Dermatol. 2020. PMID: 31437543
-
Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis.J Am Acad Dermatol. 2018 Jan;78(1):1-12. doi: 10.1016/j.jaad.2017.04.1141. J Am Acad Dermatol. 2018. PMID: 29241771 Review.
-
Alopecia areata: What's new in epidemiology, pathogenesis, diagnosis, and therapeutic options?J Dermatol Sci. 2017 Apr;86(1):3-12. doi: 10.1016/j.jdermsci.2016.10.004. Epub 2016 Oct 11. J Dermatol Sci. 2017. PMID: 27765435 Review.
-
Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity.Br J Dermatol. 2020 Jan;182(1):130-137. doi: 10.1111/bjd.18008. Epub 2019 Jul 17. Br J Dermatol. 2020. PMID: 30980732
-
Alopecia areata: What's new in the diagnosis and treatment with JAK inhibitors?J Dermatol. 2024 Feb;51(2):196-209. doi: 10.1111/1346-8138.17064. Epub 2023 Dec 12. J Dermatol. 2024. PMID: 38087654 Review.
Cited by
-
Altered hypothalamus functional connectivity and psychological stress in patients with alopecia areata.Quant Imaging Med Surg. 2025 Mar 3;15(3):1834-1844. doi: 10.21037/qims-24-1684. Epub 2025 Feb 26. Quant Imaging Med Surg. 2025. PMID: 40160661 Free PMC article.
-
Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review.J Clin Med. 2025 May 30;14(11):3881. doi: 10.3390/jcm14113881. J Clin Med. 2025. PMID: 40507644 Free PMC article. Review.
-
Evaluating the Causal Relationship Between Human Blood Metabolites and the Susceptibility to Alopecia Areata.J Cosmet Dermatol. 2025 May;24(5):e70248. doi: 10.1111/jocd.70248. J Cosmet Dermatol. 2025. PMID: 40391686 Free PMC article.
-
Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities.Cureus. 2025 Jan 31;17(1):e78298. doi: 10.7759/cureus.78298. eCollection 2025 Jan. Cureus. 2025. PMID: 40026917 Free PMC article. Review.
-
Cyclosporine-induced alopecia:a case report, FDA adverse event reporting system analysis and literature assessment.Front Pharmacol. 2024 Aug 28;15:1453034. doi: 10.3389/fphar.2024.1453034. eCollection 2024. Front Pharmacol. 2024. PMID: 39263573 Free PMC article.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Miscellaneous